1. Ayesh, R., Idle, J. R., Ritchie, J. C., Crothers, M. J., and Hetzel, M. R., 1984, Metabolic oxidation phenotypes as markers for susceptibility to lung cancer, Nature, 312:169.
2. Barbeau, A., Cloutier, T., Roy, M., Plasse, L., Paris, S., and Poirier, J., 1985, Ecogenetics of Parkinson’s disease: 4-Hydroxylation of debrisoquine, Lancet, 1:1213.
3. Black, S. D., and Coon, M. J., 1987, P-450 cytochromes: Structure and function, Advanc. Enzymol. Relat. Areas Mol. Biol., 60:35.
4. Boobis, A., Caldwell, J., DeMatteis, F., and Davies, D., 1985, “Microsomes and Drug Oxidations,” 428 p, Taylor and Francis Ltd., London.
5. Cartwright, R. A., 1984, Epidemiological studies on N-acetylation and C-center ring oxidation in neoplasia, in: “Genetic Variability in Responses to Chemical Exposure,” G. S. Omenn, and H. V. Gelboin, eds., p. 359, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.